The following data is part of a premarket notification filed by Bayer Diagnostics Corp. with the FDA for Bayer Rapidpoint 405 System.
Device ID | K020616 |
510k Number | K020616 |
Device Name: | BAYER RAPIDPOINT 405 SYSTEM |
Classification | System, Hemoglobin, Automated |
Applicant | BAYER DIAGNOSTICS CORP. 63 NORTH ST. Medfield, MA 02052 |
Contact | Thomas F Flynn |
Correspondent | Thomas F Flynn BAYER DIAGNOSTICS CORP. 63 NORTH ST. Medfield, MA 02052 |
Product Code | GKR |
CFR Regulation Number | 864.5620 [🔎] |
Decision | Substantially Equivalent (SESE) |
Type | Traditional |
3rd Party Reviewed | No |
Combination Product | No |
Date Received | 2002-02-25 |
Decision Date | 2002-07-17 |
Summary: | summary |
Device Identifier | submissionNumber | Supplement |
---|---|---|
00630414947549 | K020616 | 000 |
00630414947532 | K020616 | 000 |
00630414947525 | K020616 | 000 |
00630414553610 | K020616 | 000 |
00630414553603 | K020616 | 000 |
00630414477855 | K020616 | 000 |
00630414477848 | K020616 | 000 |
00630414477831 | K020616 | 000 |
00630414477824 | K020616 | 000 |